PER 2.38% 8.2¢ percheron therapeutics limited

anything over 25mil, page-11

  1. 61 Posts.
    Motors. As a respected member of this forum and someone who has been following the stock for 7 years. Given biotech stated our market share to be within 450-600 mill/annum(if 30 per cent reduction in IGF-1 over 3wks proven / successful), I would be interested to get your input as to what market cap ANP should realize.
    My back of page calcs include:
    -25 per cent to Isis as royalty
    -30 per cent to marketing and processing
    Leaves approximately 200-300 mill/annum less admin/taxes to say 100-150 mill/annum.
    I am interested in potential market cap after successful completion of phase 1 trials and upon commercialization.
    Reason: as long term holder not interested when 1.0 or 2.0 is hit and getting bored with daily rebuke on when this 'event may occur'.
    P.s would also like r.star input for same query
    Cheers
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
-0.002(2.38%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $24.83K 304.8K

Buyers (Bids)

No. Vol. Price($)
1 61071 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 21678 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.